{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:41:40Z","timestamp":1792798900705,"version":"4.5.0"},"reference-count":63,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center [Narodowe Centrum Nauki]","award":["NCN2012\/07\/B\/NZ7\/04375"],"award-info":[{"award-number":["NCN2012\/07\/B\/NZ7\/04375"]}]},{"name":"Medical University of Warsaw and Institute of Pharmacology PAS, Krak\u00f3w.","award":["statutory activity"],"award-info":[{"award-number":["statutory activity"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Animal studies using tests and models have demonstrated that magnesium exerts an antidepressant effect. The literature contains few studies in humans involving attempts to augment antidepressant therapy with magnesium ions. The purpose of our study was to assess the efficacy and safety of antidepressant treatment, in combination with magnesium ions. A total of 37 participants with recurrent depressive disorder who developed a depressive episode were included in this study. As part of this double-blind study, treatment with the antidepressant fluoxetine was accompanied with either magnesium ions (120 mg\/day as magnesium aspartate) or placebo. During an 8-week treatment period, each patient was monitored for any clinical abnormalities. Moreover, serum fluoxetine and magnesium levels were measured, and pharmaco-electroencephalography was performed. The fluoxetine + magnesium and fluoxetine + placebo groups showed no significant differences in either Hamilton Depression Rating Scale (HDRS) scores or serum magnesium levels at any stage of treatment. Multivariate statistical analysis of the whole investigated group showed that the following parameters increased the odds of effective treatment: lower baseline HDRS scores, female gender, smoking, and treatment augmentation with magnesium. The parameters that increased the odds of remission were lower baseline HDRS scores, shorter history of disease, the presence of antidepressant-induced changes in the pharmaco-EEG profile at 6 h after treatment, and the fact of receiving treatment augmented with magnesium ions. The limitation of this study is a small sample size.<\/jats:p>","DOI":"10.3390\/nu10081014","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T11:03:26Z","timestamp":1533294206000},"page":"1014","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response"],"prefix":"10.3390","volume":"10","author":[{"given":"Beata","family":"Ryszewska-Pokra\u015bniewicz","sequence":"first","affiliation":[{"name":"Nowowiejski Hospital, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mach","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Skalski","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Januszko","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-4114","authenticated-orcid":false,"given":"Zbigniew M.","family":"Wawrzyniak","sequence":"additional","affiliation":[{"name":"Faculty of Electronics and Information Technology, Warsaw University of Technology, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Radziwo\u0144-Zaleska","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"ref_1","unstructured":"(2018, May 15). World Health Organization. Available online: http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/depression."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pnpbp.2015.02.015","article-title":"Role of calcium, glutamate and NMDA in major depression and therapeutic application","volume":"64","author":"Deutschenbaur","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1734-1140(10)71161-0","article-title":"Interaction of glycine\/NMDA receptor ligands and antidepressant drugs in the forced swim test","volume":"62","author":"Poleszak","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0928-0987(97)86204-5","article-title":"The NMDA receptor complex and the action of antidepressant drugs in the CMS model of depression","volume":"4","author":"Nowak","year":"1996","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1734-1140(11)70716-2","article-title":"NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice","volume":"63","author":"Kasperek","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","article-title":"The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression","volume":"65","author":"Saygin","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2006.01.024","article-title":"Low Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder","volume":"61","author":"Frye","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased Levels of Glutamate in Brains from Patients with Mood Disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.12.001","article-title":"New targets for rapid antidepressant action","volume":"152","author":"Henter","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.biopsych.2017.02.214","article-title":"201. Measuring Dissociative Effects of NMDA Receptor Antagonists in the Treatment of Depression","volume":"81","author":"Sanacora","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref_11","first-page":"112","article-title":"Magnesium and depression","volume":"29","author":"Serefko","year":"2016","journal-title":"Magnes. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2007.07.018","article-title":"NMDA\/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice","volume":"88","author":"Poleszak","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpsychires.2013.02.015","article-title":"Ketamine, magnesium and major depression\u2014From pharmacology to pathophysiology and back","volume":"47","author":"Murck","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","article-title":"Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs","volume":"30","author":"Gould","year":"2005","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pnpbp.2008.11.007","article-title":"Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium","volume":"33","author":"Cardoso","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_16","first-page":"32","article-title":"Magnesium intake and serum C-reactive protein levels in children","volume":"20","author":"King","year":"2007","journal-title":"Magnes. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0091-3057(96)00555-2","article-title":"NMDA receptor complex blockade by oral administration of magnesium: Comparison with MK-801","volume":"58","author":"Decollogne","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2004.01.006","article-title":"Antidepressant- and anxiolytic-like activity of magnesium in mice","volume":"78","author":"Poleszak","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1461145713001089","article-title":"Antidepressant-like activity of magnesium in the chronic mild stress model in rats: Alterations in the NMDA receptor subunits","volume":"17","author":"Pochwat","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-014-3671-6","article-title":"Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA\/BDNF pathway","volume":"232","author":"Pochwat","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pbb.2005.03.017","article-title":"Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice","volume":"81","author":"Poleszak","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1734-1140(13)71032-6","article-title":"Magnesium in depression","volume":"65","author":"Serefko","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuropharm.2004.08.010","article-title":"Magnesium-deficient diet alters depression- and anxiety-related behavior in mice\u2014Influence of desipramine and Hypericum perforatum extract","volume":"47","author":"Singewald","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00048670802534408","article-title":"Association between magnesium intake and depression and anxiety in community-dwelling adults: The Hordaland Health Study","volume":"43","author":"Jacka","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2891-11-41","article-title":"Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: A cross-sectional study","volume":"11","author":"Huang","year":"2012","journal-title":"Nutr. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3122\/jabfm.2015.02.140176","article-title":"Magnesium intake and depression in adults","volume":"28","author":"Tarleton","year":"2015","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jad.2015.12.056","article-title":"Dietary magnesium intake and the incidence of depression: A 20-year follow-up study","volume":"193","author":"Yary","year":"2016","journal-title":"J. Affect Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-0447.1989.tb03021.x","article-title":"Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms","volume":"80","author":"Linder","year":"1989","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.arcmed.2007.03.008","article-title":"Depressive symptoms and hypomagnesemia in older diabetic subjects","volume":"38","year":"2007","journal-title":"Arch. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1179\/1476830512Y.0000000044","article-title":"Magnesium and depression: A systematic review","volume":"16","author":"Derom","year":"2013","journal-title":"Nutr. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1179\/1476830512Y.0000000002","article-title":"Plasma magnesium levels and treatment outcome in depressed patients","volume":"15","author":"Camardese","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care","volume":"8","author":"Bauer","year":"2007","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"ref_33","first-page":"222","article-title":"Defining treatment-resistant depression: A comprehensive review of the literature","volume":"26","author":"Trevino","year":"2014","journal-title":"Ann. Clin. Psychiatry Off. J. Am. Acad. Clin. Psychiatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharep.2015.06.109","article-title":"Therapeutic drug monitoring of depression\u2014Amplification by magnesium ions","volume":"67","author":"Skalski","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.mehy.2006.01.047","article-title":"Rapid recovery from major depression using magnesium treatment","volume":"67","author":"Eby","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3945\/jn.111.155572","article-title":"Magnesium intake is not related to depression risk in Spanish university graduates","volume":"142","author":"Derom","year":"2012","journal-title":"J. Nutr."},{"key":"ref_37","first-page":"5","article-title":"Monitored therapy of depression","volume":"3","author":"Matsumoto","year":"1998","journal-title":"Farmakoterapia w Psychiatrii i Neurologii"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00007691-199308000-00008","article-title":"Concurrent liquid chromatographic measurement of fluoxetine, amitryptyline, imipramine, and their active metabolites norfluoxetine, nortyptyline, and desipramine in plasma","volume":"15","author":"Raines","year":"1993","journal-title":"Ther. Drug. Monit."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-4347(97)00327-7","article-title":"Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection","volume":"700","author":"Aymard","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007691-199802000-00003","article-title":"Routine measurement of fluoxetine and norfluoxetine by high-performance liquid chromatography with ultraviolet detection in patients under concomitant treatment with tricyclic antidepressants","volume":"20","author":"Meineke","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"ref_42","unstructured":"Komorowska, E. (2002). Walidacja i Zastosowanie Metody Oznaczania Fluoksetyny Technik\u0105 HPLC, Akademia Medyczna w Warszawie, Wydzia\u0142 Farmaceutyczny."},{"key":"ref_43","unstructured":"Baldessarini, R.J. (1996). Drugs and treatment of psychiatric disorders: Depression and mania. W. Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutic, McGraw-Hills Co."},{"key":"ref_44","unstructured":"Littlejohn, D., and Thorburn Burns, D. (1994). Magnesium; Clinical Significance and Analytical Determination, RSC. Reviews on Analytical Chemistry, Euroanalysis VIII."},{"key":"ref_45","first-page":"52","article-title":"Farmakoelektroencefalografia: Aktualny stan wiedzy i perspektywy","volume":"24","author":"Szelenberger","year":"1990","journal-title":"Psychiatr. Polska"},{"key":"ref_46","first-page":"60","article-title":"Zastosowanie metody farmakoelektroencefalografii (farmako\u2014EEG) w monitorowaniu terapii depresji","volume":"4","author":"Skalski","year":"1995","journal-title":"Farmakoterapia w Psychiatrii i Neurologii"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Tarleton, E.K., Littenberg, B., MacLean, C.D., Kennedy, A.G., and Daley, C. (2017). Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180067"},{"key":"ref_49","first-page":"218","article-title":"Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: A randomized, equivalent trial","volume":"21","year":"2008","journal-title":"Magnes. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pcn.12480","article-title":"Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate versus 5% dextrose on depressive symptoms in adults with treatment-resistant depression","volume":"71","author":"Mehdi","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/03630242.2016.1235074","article-title":"Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial","volume":"57","author":"Fard","year":"2017","journal-title":"Women Health"},{"key":"ref_52","first-page":"102","article-title":"Magnesium intake and depression: The SUN cohort","volume":"29","year":"2016","journal-title":"Magnes. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"163s","DOI":"10.1684\/mrh.2009.0177","article-title":"Magnesium in major depression","volume":"22","author":"Nechifor","year":"2009","journal-title":"Magnes. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-007-0714-8","article-title":"Modulation of antidepressant-like activity of magnesium by serotonergic system","volume":"114","author":"Poleszak","year":"2007","journal-title":"J. Neural Transm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-1781(94)90033-7","article-title":"CSF magnesium in affective disorder: Lack of correlation with clinical course of treatment","volume":"51","author":"George","year":"1994","journal-title":"Psychiatry Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(72)91478-X","article-title":"Sex difference in mean serum-magnesium levels in depression","volume":"1","author":"Herzberg","year":"1972","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/07315724.1987.10720193","article-title":"Serum magnesium in women during pregnancy, while taking contraceptives, and after menopause","volume":"6","author":"Stanton","year":"1987","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ntr\/ntt134","article-title":"Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers","volume":"16","author":"Brown","year":"2014","journal-title":"Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4278\/0890-1171-20.3.179","article-title":"Depressive symptoms and cigarette smoking in American workers","volume":"20","author":"Kenney","year":"2006","journal-title":"Am. J. Health Promot. AJHP"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pnpbp.2004.08.008","article-title":"Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine","volume":"29","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(00)05064-9","article-title":"Smoking cessation and the course of major depression: A follow-up study","volume":"357","author":"Glassman","year":"2001","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02246496","article-title":"Effects of transderman nicotine on mood and sleep in nonsmoking major depresssed patients","volume":"121","year":"1995","journal-title":"Psychopharmacology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/1871527313666140612105254","article-title":"Nicotine effects on human affective functions: A systematic review of the literature on a controversial issue","volume":"13","author":"Cosci","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/8\/1014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:16:26Z","timestamp":1760195786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/8\/1014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["nu10081014"],"URL":"https:\/\/doi.org\/10.3390\/nu10081014","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]}}}